La puesta en el mercado de Fungifree AB®, es el producto de más de una década de trabajo de investigadores mexicanos. El desarrollo del proyecto, involucró desde los primeros estudios de ciencia básica, hasta el otorgamiento de los registros de uso por
Enrique Galindo +6 more
doaj
La ventaja estratégica de las empresas biofarmacéuticas de alta tecnología, depende cada día más de su capacidad para acumular activos intangibles mediante un proceso cuidadosamente planificado y ejecutado de creación de competencias laborales.
Yanela Cadalzo-Díaz +3 more
doaj
[Peripheral promises: expectations, coalitions and covid-19 vaccines in Argentina]. [PDF]
Sanmartin MC, Bortz G.
europepmc +1 more source
[Technological healthcare management arrangements: challenges for contemporary hospitals]. [PDF]
Chioro A, Correia T.
europepmc +1 more source
Pressure on bony prominences in the dorsal, lateral, and ventral decubitus: a clinical trial. [PDF]
Borges EL +4 more
europepmc +1 more source
Technology transfer for COVID-19 vaccine in the Institute of Technology in Immunobiologicals (Bio-Manguinhos), Oswaldo Cruz Foundation. [PDF]
Rosenberg VZ, Antunes AMS.
europepmc +1 more source
[Home Respiratory Therapies: SEPAR Technical Document for Institutional Decision Support]. [PDF]
Marcos PJ +4 more
europepmc +1 more source
[Usefulness and acceptance of telephone monitoring by a virtual assistant for patients with COVID-19 following discharge]. [PDF]
García Bermúdez I +5 more
europepmc +1 more source
[Organizational culture: The influence of leadership in improving institutional health processes]. [PDF]
Legorreta-Rojas M, Trejo-Amador U.
europepmc +1 more source
[Hepatitis B in indigenous people in Latin America: a literature reviewHepatite B em indígenas na América Latina: revisão da literatura]. [PDF]
Castro-Arroyave DM +4 more
europepmc +1 more source

